TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion
Article in Frontiers in Immunology (January 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (January 2024)
Article in Frontiers in Oncology (September 2023)
Article in Mathematical Biosciences and Engineering (January 2023)